head JofIMAB
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2020, vol. 26, issue4
Subject Area: Medicine
DOI: 10.5272/jimab.2020264.3469
Published online: 24 November 2020

Review article

J of IMAB. 2020 Oct-Dec;26(4):3469-3474
Desislava MarinovaORCID logo Corresponding Autoremail, Maya DanovskaORCID logo,
Department Neurology and Neurosurgery, Faculty Medicine, Medical University, Pleven, Bulgaria.

Parkinson's disease (PD) is the second most common neurodegenerative disorder after the dementia of Alzheimer. The clinical presentation of PD is dominated by typical motor symptoms as resting tremor, cogwheel rigidity, bradykinesia, and postural instability. Non-motor symptoms (NMS) of Parkinson's disease are common but are often under-recognized in clinical practice either due to the lack of spontaneous complaints by the patients or to the absence of systematic questioning by healthcare professionals. In contrast to motor dysfunctions, non-motor symptoms frequently remain unreported. Recently, a self-completed NMS questionnaire and NMS scale for identification and evaluation of these symptoms have been validated. An international survey has shown that up to 62% of NMS in PD remain undeclared to healthcare professionals because patients are unaware that NMS symptoms are linked to PD. Based on both clinical and neuropathological data, PD, traditionally accepted as a dopaminergic motor disorder, now can be characterized as a multisystem neurodegenerative disease that involves many neurotransmitter systems and affects not only motor but non-motor functions, too.

Keywords: Parkinson's disease (PD), Non-motor symptoms (NMS), quality of life,

pdf - Download FULL TEXT /PDF 515 KB/
Please cite this article as: Marinova D, Danovska M. The non-motor symptoms–challenge in diagnosis of Parkinson's Disease. J of IMAB. 2020 Oct-Dec;26(4):3469-3474. DOI: 10.5272/jimab.2020264.3469

Corresponding AutorCorrespondence to: Dr Desislava Marinova, Department of Neurology and Neurosurgery, Neurology Clinic, Medical University - Pleven; 1, St Kliment Ohridski str., 5800 Pleven, Bulgaria; E-mail: desislavamar@gmail.com

1. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4. [PubMed]
2. Pringsheim T, Jette N, Frolkis A, Steeves TDL. The prevalence of Parkinson'sdisease: a systematic review and meta-analysis. MovDisord. 2014Nov;29(13):1583-90. [PubMed]
3. Tysnes O-B, Storstein A. Epidemiology of Parkinson's disease. J Neural Transm (Vienna). 2017 Aug;124(8):901-905. [PubMed]
4. Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003 Jun 1;157(11):1015-22. [PubMed]
5. Chorbadzhieva E. [Treatment of patients with late Parkinson's Disease with Levodopa / Carbidopa Intestinal Gel.][Dissertation] Medical University Sofia. 2018.[in Bulgarian]
6. Bonnet AM, Jutras MF, Czernecki V, Corvol JC, Vidailhet M. Nonmotor symptoms in Parkinson's disease in 2012: relevant clinical aspects. Parkinsons Dis. 2012;2012:198316. [PubMed]
7. Chaudhuri KR, Healy DG, Schapira AHN. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 2006 Mar;5(3):235-45. [PubMed]
8. Chaudhuri KR, Odin P, Antonini A, Martinez-Martin P. Parkinson's disease: the non-motor issues. Parkinsonism Relat Disord.  2011 Dec;17(10):717-23. [PubMed]
9. Bassetti CL. Non-motor disturbances in Parkinson's disease. Neurodegenerative Dis. 2011; 8(3):95-108. [PubMed]
10. Reijnders JSAM, Ehrt U, Weber WEJ, Aarsland D, Leentjens AFG. A Systematic Review of Prevalence Studies of Depression in Parkinson's Disease. Mov Disord. 2008Jan 30;23(2):183-9. [PubMed]
11. Chen P-H, Cheng S-J. Depression in Parkinson Disease: Current Understanding and Treatment. Int J Gerontol. 2008 Dec;2(4):172-182. [Crossref]
12. Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010 May;67(5):589-95. [PubMed]
13. Evans AH, Lees AJ, Dopamine dysregulation syndrome in Parkinson's disease. Curr Opin Neurol. 2004 Aug;17(4):393-8. [PubMed].
14. Goetz CG, Ouyang B, Negron A, Stebbins GT. Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study. Neurology.  2010 Nov 16;75(20):1773-9. [PubMed]
15. Hely MA, Reid WG, Adena MA, Glenda MH, Morris JGL. The Sydney Multicenter Study of Parkinson's Disease: The Inevitability of Dementia at 20 years. MovDisord.2008 Apr 30;23(6):837-44. [PubMed]
16. Rohegera M, Kalbea E, Liepelt-ScarfonebI. Progression in cognitive decline in Parkinson's disease.J Parkins Dis. 2018; 8(2):183-193. [PubMed]
17. Lenka A, Herat P, Mitta S, Pal P.Sleep disturbances in patients with Parkison's disease: it's time to wake up. Ann Mov Dis. 2018; 1(1):8-19.
18. Sobreira-Neto MA, Pena-Pereira MA, Sobreira EST, Chagas MHN, Fernandes RMF, Tumas V, et al. High Frequency of Sleep Disorders in Parkinson's Disease and Its Relationship with Quality of Life. Eur Neurol. 2017;78(5-6):330-337. [PubMed]
19. Chahine LM, Amara AW, Videnovic A. A Systematic Review of the Literature on Disorders of Sleep and Wakefulness in Parkinson's Disease From 2005-2015. Sleep Med Rev. 2016Oct;35:33-50. [PubMed]
20. Marinus j, K Zhu, Marras C, Aarsland D, J van Hilten. Risk factors for non-motor symptoms in Parkinson's disease. Lancet Neurol.2018 Jun;17(6):559-568. [PubMed]
21. Dauvilliers Y, Schenck CH, Postuma RB, Iranzo A, Luppi P-H, Plazzi G, et al. REM sleep behaviour disorder. Nat Rev Dis Primers. 2018 Aug 30;4(1):19. [PubMed]
22. Klingelhoefer L, Bhattacharya K, Reichmann H. Restless legs syndrome. Clin Med (Lond). 2016 Aug;16(4):379-82. [PubMed]
23. Iwaki H, Hughes KC, Gao X, Schwarzschild MA, Ascherio A. The association between restless legs syndrome and premotor symptoms of Parkinson's disease. J Neurol Sci. 2018 Nov 15;394:41-44. [PubMed]
24. Li Y, Wang W, Winkelman JW, Malhotra A, Ma J, Gao X.Prospective study of restless legs syndrome and mortality among men. Neurology.2013 Jul 2;81(1):52-9.[PubMed]
25. Covassin N, Neikrug AB, Liu L, Corey-Bloom J, Loredo JS, PalmerBW, et al. Clinical correlates of periodic limb movements in sleep in Parkinson's disease. J Neurol Sci.2012 May 15;316(1-2):131-6. [PubMed]
26. Chou P-S, Lai C-L, Chou Y-H, Chang W-P. Sleep apnea and the subsequent risk of Parkinson's disease: a 3-year nationwide population-based study. Neuropsychiatr Dis Treat. 2017 Mar 30;13:959-965. [Crossref]
27. Harmell AL, Neikrug AB, Palmer BW, Avanzino JA, Liu L, Maglione JE, et al. Obstructive Sleep Apnea and Cognition in Parkinson's disease. Sleep Med. 2016 May;21:28-34. [PubMed]
28. Kostić V, Tomić A, Ječmenica-Lukić M. The Pathophysiology of Fatigue in Parkinson's disease and its Pragmatic Management. Mov Disord ClinPract. 2016 Mar 11;3(4):323-330. [PubMed]
29. Friedman JH, Brown RG, Comella C, Garber CE, Krupp LB, Lou J-S, et al. Fatigue in Parkinson's disease: a review. MovDisord. 2007 Feb 15;22(3):297-308. [PubMed]
30. Stocchi F, Abbruzzese G, Ceravolo R, Cortelli P, D'Amelio M, De Pandis MF, et al. Prevalence of fatigue in Parkinson disease and its clinical correlates. Neurology. 2014 Jul 15;83(3):215-20. [PubMed]
31. Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, et al. The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. MovDisord. 2009 Aug 15;24(11):1641-9. [PubMed]
32. Rahman S, Griffin HJ, Quinn NP, Jahanshahi M. Quality of life in Parkinson's disease: the relative importance of the symptoms. MovDisord. 2008Jul 30;23(10):1428-34. [PubMed]
33. Chen Z, Li G, Liu J. Autonomic dysfunction in Parkinson's disease: Implications for pathophysiology, diagnosis, and treatment. Neurobiol Dis. 2020 Feb;134:104700. [PubMed]
34. Asahina M, Vichayanrat E, Low DA, Iodice V, Mathias CJ. Autonomic dysfunction in parkinsonian disorders: assessment and pathophysiology. J Neurol Neurosurg Psychiatry. 2013 Jun;84(6):674-80. [PubMed]
35. Cersosimo MG, Raina GB, Pellene LA, Micheli FE, Calandra CR, Maiola R. Weight Loss in Parkinson's Disease: The Relationship with Motor Symptoms and Disease Progression. Biomed Res Int. 2018 Jul 9;2018:9642524. [PubMed]
36. Pfeiffer RF. Management of Autonomic Dysfunction in Parkinson's Disease. Semin Neurol. 2017 Apr;37(2):176-185. [PubMed]
37. Pasricha PJ, Parkman HP. Gastroparesis: definitions and diagnosis. Gastroenterol Clin North Am. 2015 Mar;44(1):1-7. [PubMed]
38. van Wamelen DJ, Leta V, Podlewska AM, Wan Y-M, Krbot K, Jaakkola E, et al. Exploring hyperhidrosis and related thermoregulatory symptoms as a possible clinical identifier for the dysautonomic subtype of Parkinson's disease. J Neurol. 2019 Jul;266(7):1736-42. [PubMed]
39. Umehara T, Nakahara A, Matsuno H, Toyoda C, Oka H. Predictors of postprandial hypotension in elderly patients with de novo Parkinson's disease. J Neural Transm (Vienna). 2016 Nov;123(11):1331-9. [PubMed]
40. Espay AJ, LeWitt PA, Hauser RA, Merola A, Masellis M, Lang AE.Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritization of treatment targets. Lancet Neurol. 2016 Aug;15(9):954-966. [PubMed]
41. Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017 Jul;18(7):435-450. [PubMed
42. Doty RL. Olfaction in Parkinson's disease and related disorders. Neurobiol Dis. 2012 Jun;46(3):527-52. [PubMed] [Crossref].

Received: 28 October 2019
Published online: 24 November 2020

back to Online Journal